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Background. The purpose of this prospective study was first to evaluate the safety and effectiveness of Minimally Invasive Distal
Metatarsal Metaphyseal Osteotomy (DMMO) in treating central metatarsalgia, identifying possible contraindications. The second
objective was to verify the potential ofDMMO to restore a harmonious forefootmorphotype according toMaestro criteria.Methods.
A consecutive series of patients with metatarsalgia was consecutively enrolled and treated by DMMO. According to Maestro
criteria, preoperative planning was carried out by both clinical and radiological assessment. Patient demographic data, AOFAS
scores, 17-FFI, MOXFQ, SF-36, VAS, and complications were recorded. Maestro parameters, relative morphotypes, and bone callus
formation were assessed. Statistical analysis was carried out (p < 0.05). Results. Ninety-three patients (93 feet) with a mean age of
62.4 (31-87) years were evaluated. At mean follow-up of 58.7 (36-96) months, all of the clinical scores improved significantly (p
< 0.0001). Most of the osteotomies (76.3%) had healed by 3-month follow-up, while ideal harmonious morphotype was restored
only in a few feet (3.2%). Clinical and radiological outcomes were not different based on principal demographic parameters. Long-
term complications were recorded in 12 cases (12.9%). Conclusion. DMMO is a safe and effective method for the treatment of
metatarsalgia. Although Maestro criteria were useful to calculate the metatarsal bones to be shortened and a significant clinical
improvement of all scores was achieved, the ideal harmonious morphotype was restored only in a few feet. Hence, our data show
that Maestro criteria did not have a predictive value in clinical outcomes of DMMO.
1. Introduction
Central metatarsalgia, one of the most common problems
in orthopaedic clinical practice, is a term used to indi-
cate a painful condition localized in the plantar forefoot
region between the 2nd and 4th metatarsal heads and/or
the metatarsophalangeal joint [1–3], often associated with
the most frequent forefoot disorders, such as hallux valgus
(HV) and lesser toe deformities. Ten percent of the general
population has had some form of pain in the metatarsal
region during their lifetime, the majority being female [4, 5].
This condition is not a diagnosis but a symptom for which
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there can be several contributing factors [6]. Metatarsalgia
syndrome can be classified as primary or biomechanical,
secondary, and iatrogenic [3, 7, 8]. Primary or biomechanical
metatarsalgia is the most important, accounting for about
90% of cases [2]. It is caused by intrinsic abnormalities
of metatarsal anatomy and the relationship between the
metatarsal bones (MBs) and the rest of the foot, resulting
in an overload to the forefoot [5]. Its most common cause
is a long second MB [9]. Individuals presenting congenital
brevity of the 1st metatarsal (M1) or severe HVmay complain
of pain in the forefoot caused by incompetence of the first
ray in its weight-bearing function, creating transfer pressure
to lesser metatarsal, in particular the 2nd metatarsal (M2).
Other causes of primarymetatarsalgia include disproportion-
ate length ofM2 or the 3rdmetatarsal (M3), congenital defor-
mities of the metatarsal heads, tightness of the gastrocnemius
muscles or triceps, fixed equinus of the foot, pes cavus, and
any hindfoot abnormality that results in overloading of the
forefoot [10, 11]. Maestro and Besse have studied forefoot
structure to define ideal forefoot morphology with precise
criteria [9]. Forefoot alterations cause imbalance in weight-
bearing distribution that may lead to mechanical overload
on the affected metatarsal heads and may evolve to pain and
plantar callosities [4, 12].
First-stepmetatarsalgia treatment is conservative, includ-
ing physical therapy and stretching exercises for gastroc-
soleous tightness, functional foot orthoses and shoe modifi-
cations to lessen the pressure on the forefoot, debridement of
calluses associated with painful keratosis when present, and
judicious use of corticosteroid injections [13]. These can be
sufficient to achieve satisfactory results in 85% of cases [8]
and should always be carried out before considering surgery
in the management of this condition [3].
However, when these conservative measures fail and
the metatarsalgia becomes recalcitrant, it requires surgical
treatment with or without procedures on the first ray [14, 15].
The primary goal of surgery is to relieve pain and restore
an ideal forefoot morphology with a normal distribution of
pressure in the forefoot [16–18]. Multiple surgical procedures
have been described for this syndrome [1, 19–26]. However,
the Weil osteotomy (and its modifications) has been the
preferred technique employed by surgeons for many years in
Europe [17, 26, 27]. This procedure consists of an open intra-
articular osteotomy performed after preoperative planning
based on the Maestro’s criteria to calculate the appropriate
metatarsal length from anteroposterior standing radiographs
[9, 11, 27, 28], which provides longitudinal decompression.
Although it was originally designed to restore the physio-
logic cascade of the lesser MBs and evenly redistribute the
pressures on the forefoot, the main complication, estimated
to be among at least 10 to 30% of cases, is postoperative
stiffness, while other commonly described problems include
floating toe, recurrence, and transfermetatarsalgia [8, 29–32].
For these reasons, this procedure has generated considerable
controversy.
Within the last decade, innovative Distal Metatarsal
Metaphyseal Osteotomy (DMMO) has proved to be an
alternative surgical approach, being a percutaneous extra-
articular metatarsal neck osteotomy without any internal
fixation [19, 20, 29], which permits the metatarsal lengths
to be set automatically upon weight bearing. This technique
results in less postoperative stiffness than the standard Weil
osteotomy [17]. More recently, this percutaneous procedure
was modified to reduce the plantar pressure of the MBs over
chronic plantar ulcers in diabetic patients, promoting ulcer
healing [33].
Hence, the primary purpose of this prospective study was
to specifically evaluate the safety and effectiveness of Min-
imally Invasive Distal Metatarsal Metaphyseal Osteotomy
(DMMO) in treating patients with persistent central primary
metatarsalgia, associated or not with HV and lesser toe
deformities, identifying possible contraindications in relation
to some demographic parameters (age, gender, BMI, and
smoking). The second objective was to verify the potential
of DMMO in restoring a harmonious foot morphotype
according to Maestro’s criteria and if these radiographic
parameters are correlated with clinical outcomes, maintain-
ing the predictive value of these criteria during preoperative
planning also for this percutaneous surgery.
2. Material and Methods
2.1. Patients. At our institution, between January 2009 and
December 2013, a consecutive series of 131 Caucasian patients
with diagnosis of central primary metatarsalgia resistant
to conservative treatment was enrolled in this prospective
study. All patients underwent DMMO, performed by a single
surgeon, the senior author (C.B.), trained in minimally inva-
sive surgery (MIS), who followed and checked the patients
personally during the postoperative period. All subjects
participating in this study received a thorough explanation
of the risks and benefits of inclusion and gave their oral
and written informed consent to publish the data. This study
was approved by the Institutional Ethics Committee and
performed in accordance with the ethical standards of the
1964 Declaration of Helsinki as revised in 2000 and those of
Good Clinical Practice.
2.2. Inclusion and Exclusion Criteria. Patients with diagnosis
of central primary metatarsalgia between M2 and M4 of a
biomechanical etiology in the plantar foot area were enrolled
consecutively and prospectively with precise inclusion crite-
ria over a 5-year period. Ages ranged from 18 to 90 years.
Only symptomatic patients with persistent pain, with or
without forefoot plantar hyperkeratosis lesions, unresponsive
to conservative and orthotic treatment performed for at
least 6 months, were included in this study and underwent
DMMO on a single foot. Associated forefoot pathologies
included HV, metatarsophalangeal (MTP) joint instability
or dislocation, and flexible or fixed lesser toe deformities.
Exclusion criteria were as follows: arthritis and stiffness of
MTP joint, congenital deformities of the foot, hallux rigidus,
Freiberg’s infraction, Morton’s neuroma, and diagnosis of
rheumatic, metabolic, neurologic, infective, or psychiatric
pathologies. Furthermore, patients were excluded if they had
previous trauma or foot and ankle surgery, or any form of
secondary or iatrogenic metatarsalgia.
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Figure 1: Maestro criteria: example of radiographic marks, relative
measurements (millimeters in white) for each lesser MB, and
their difference with the consecutive one (millimeters in red) on
anteroposterior radiographs of a forefoot of our series, performed to
calculate the number of MBs to be shortened during radiographic
planning and to identify the corresponding morphotype pre- and
postoperatively. According to these criteria, the forefoot was classi-
fied as “unclassified non-harmonious” in the preoperative period (A)
and as “non-harmonious 1” at the last follow-up after DMMO (B).
Endolog technique was also performed for HV correction.
2.3. Preoperative Planning. Both clinical and radiological
assessment were used for preoperative planning. The general
aspects of metatarsalgia were evaluated: affected side, plantar
hyperkeratosis lesions, site of metatarsalgia, symptomatic
MTP joint instability (using the Lachman test), and rela-
tive clinical signs of dorsal dislocation. With these data, it
was decided where the osteotomy should lead to rebalance
plantar pressures and create a harmonious curve, with a
tolerance of ±1mm for Maestro criteria 1 and 2, ±2mm
for Maestro criteria 3. A normal or harmonious forefoot
shows a geometrical progression of 2 regarding the relative
lengths of the lessermetatarsals compared to the SM4 line, the
line passing through the mid-third of the M4 head (+2mm
proximally/center M4 head/-4mm distally). The line of the
osteotomy was drawn from the center of the lateral sesamoid
through the central or distal third of theM4 head, perpendic-
ular to the axis of the foot (Figure 1).TheDMMOwas carried
out only on the metatarsal of symptomatic MTP joints unless
this shortening would make the neighboring metatarsal too
long, resulting in a disharmonious morphotype with a high
risk of a transfer lesion. The adjacent metatarsal was also
shortened in these cases.
In a second step, associated deformities, when present,
were assessed and then corrected during the same operation.
Surgical procedures on the first raywere performed according
to our institutional protocol: HV correction by Reverdin-
Ishampercutaneous osteotomy formild-moderate deformity,
or Endolog technique for moderate-severe deformity, both
generally followed by percutaneous Akin osteotomy [29,
Figure 2: Distal Metatarsal Metaphyseal Osteotomy (DMMO): dis-
section of the dorsumof the foot showing the extensor apparatus and
the innervation pattern of the foot and toes. Blue circles highlight the
incision points for percutaneous DMMO (A). Bone preparation of
an idealDMMOprocedure performed at the level of theM-neck and
the final result showing the shortening and elevation of the M-head
(B).Weight-bearing lateral radiographic view showing the site of the
DMMO (red arrow) on each lesser MB; green arrow corresponds
to Reverdin-Isham osteotomy for HV correction during the same
operation (C).
34]. In addition, percutaneous lateral soft-tissue release and
percutaneous tenotomy of extensor and/or flexor, in associa-
tion with (or not) phalange percutaneous osteotomies, were
tailored based on the lesser toe deformities, flexible or fixed.
2.4. Operative Technique. The surgical technique is per-
formed according to the sameprinciples and the same general
indications described by M. De Prado [20, 21] (Figure 2).
During the operation, the patient is in a supine position, with
the operated foot protruding from the table. No ankle joint
tourniquet is applied, as it is not required for this technique.
Prophylactic antibiotic (Cefazolin: 2 g) is administered before
surgery. The anesthesiologist performs a regional block of
the foot, involving superficial nerves (saphenous, sural, and
superficial peroneal) and deep nerves (deep peroneal and
tibial).
2.5. Minimally Invasive Distal Metatarsal Metaphyseal Oste-
otomy (DMMO). The surgeon holds the metatarsopha-
langeal joint between the thumb and index finger of his non-
dominant hand [19]. Using a small scalpel blade (SM64) in his
dominant hand, an incision of 5mm is made parallel to the
extensor tendons at the dorsal side of the medial (or lateral)
border of each metatarsal head that needs to be shortened
(Figures 2(A) and 3(A)) [14].The side of the incision depends
on the surgeon’s handedness and which foot is being operated
on. The scalpel is advanced at an oblique angle of about 45∘
until it reaches the dorsal aspect of the distal MB, at the
neck level, to undergo osteotomy (Figure 3(A)). Through the
same incision, first a bone rasp specific for percutaneous
surgery is inserted, using it to separate the periosteum at the
level of the osteotomy site (Figure 3(B)). Then, a Shannon
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Figure 3: DMMO intraoperative images (1st): using a small scalpel blade (SM64), an incision of 3-5mm was made parallel to the extensor
tendons at the dorsal side of the medial border of each M-head that needed to be shortened. The scalpel was advanced at an oblique angle
of about 45∘ until it reached the dorsal aspect of the distal MB at the level of the neck (A). Through the same incision, first a bone rasp was
inserted, using it to separate the periosteum at the level of osteotomy (B). Then, a Shannon Isham burr (2.0 × 12mm) was introduced until it
reached the metatarsal neck (C). Fluoroscopy was used to confirm the correct position of the osteotomy site on the distal metaphysis of the
MB (D).
Figure 4: DMMO intraoperative images (2nd): in this position, the DMMO was performed with an angle of approximately 45∘ with respect
to the long axis of the MB in a dorsal-distal to proximal-plantar direction, with rotary motion, extending to the contralateral cortex (A). To
verify the completion of the osteotomy of each MB operated on, manual traction on the corresponding toe was applied under fluoroscopic
control (B). Before closing the wounds by resorbable sutures (C), theMBs weremanually compacted, applying pressure in the distal-proximal
direction, pushing their heads dorsally. Finally, after bandage application, a final radiographic check was made to evaluate the correction
obtained (D).
Isham burr (2.0 × 12mm), adapted for Mm960 (produced
by Medic Micro, Switzerland), is introduced until it reaches
the metatarsal neck where the periosteum was previously
removed (Figure 3(C)). Fluoroscopy is used to confirm the
correct position of the osteotomy site on the distal diaphysis
of the MB (Figure 3(D)). In this position, the cutting is
started with an angle of approximately 45∘ with respect to
the long axis of the MB in a dorsal-distal to proximal-plantar
direction, with rotary motion, extending to the contralateral
cortex (Figures 2(B) and 4(A)). In this way, the lateral cortical
surface is cut first, then the plantar, medial, and, lastly, the
dorsal cortical surface. During the osteotomy process, the
incision site is irrigated by normal saline, as the burr can
cause excessive heat, causing first skin burn and resulting
subsequently in fibrosis and pseudoarthrosis at the bone
level. Further, this lavage is useful to remove bone debris,
preventing periarticular ossifications in the stab canal. To
verify the completion of the osteotomy of each MB operated
on, manual traction on the corresponding toe was applied
under fluoroscopic control (Figure 4(B)). Upon completion
of the osteotomy, the bone is manually compacted, applying
pressure in the distal-proximal direction of the interested
metatarsal, pushing the metatarsal head dorsally and produc-
ing contact of the trabecular bone, since no internal fixation
is performed (Figure 2(C)). In our cohort, the number
of metatarsal osteotomies performed in each forefoot was
planned according to how much the metatarsal formula was
altered according to the Maestro criteria (Figure 1). Before
closing the wounds by resorbable sutures (Figure 4(C)), a
final radiographic check was made to evaluate the correction
obtained (Figure 2(D)).
2.6. Bandage. Because there is no osteosynthesis material in
this surgery, the bandage is a very important tool in order
to maintain the metatarsal head position achieved with the
operation. Consequently, its application was performed with
the utmost care and attention. The crisscross bandage was
traced between all intermetatarsal spaces, crossing it over the
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medial (lateral) aspect of all of the osteotomies performed in
order to reinforce the strength of the bandage. Gentle traction
was used to maintain the toe in light hypercorrection and
plantar inclination. Finally, the forefoot was covered with
tubular gauzes, except for the distal part of the toes and nails.
2.7. Postoperative Protocol. All patients followed the same
postoperative protocol and were followed in the same stan-
dardized manner by the senior author (C.B.). The patients
were allowed to walk as much as they could tolerate the
day after surgery using a rigid flat-soled orthopedic shoe
for the following 30-day period. The patient was discharged
the same day, warned of the possible persistence of swelling
for 1-3 months, of pain, and of the presence of clicks in the
forefoot due to movements in the osteotomy sites. This factor
is very important as metatarsal length sets automatically
upon weight bearing of the foot [9, 14]. Anteroposterior
and lateral X-rays of non-weight-bearing feet were taken
before the patients were discharged. We recommended an
antibiotic oral prophylaxis for a week, as well as thromboem-
bolic prophylaxis (Natrium Enoxaparin: 4.000 IU/day) and
an anti-edemigen therapy (Leucoselect, Lymphaselect, and
Bromelina: 1 tablet/day) for 30 days starting from the day of
the surgery. Moreover, an analgesic therapy was prescribed
for 2 weeks of Etoricoxib (90 or 60mg, 1 tablet/day) in
the morning, also to prevent heterotopic ossification when
the comorbidities of the patient permitted, or, alternatively,
Paracetamol (1g, 1 tablet 2x/day). All of the patients were seen
once a week for amonth in our outpatient clinic.Thefirst visit
was 8 days after surgery. The original bandage was removed
and substituted by a simpler bandage. During the 3 weekly
visits, the bandage was changed in the same way. One month
after surgical treatment, the bandage was totally removed
after taking anteroposterior weight-bearing and lateral X-
rays. The patients were then able to walk with comfortable
shoes, allowing total load on the operated foot. No specific
physiokinetic therapy was suggested to restart daily activities.
However, controlled return to sports was not allowed for 3
months after surgery.
2.8. PatientAssessment. Theclinical and radiological analyses
were carried out, respectively, by two independent investi-
gators, the junior authors (W.T.K.K. and A.Z.), not involved
in the primary surgical treatment of the patients. For this
study, all patients were subjected to clinical and radiographic
evaluation with the same protocol prior to surgery as well
as regular follow-ups, following our institutional standard
aftercare algorithm, according to this study protocol, to
AOFAS accepted guidelines [15, 35], and based on the Mae-
stro criteria [9]. For methodological reasons, the immediate
postoperative X-rays at discharge, as well as the one-month
radiographic control, were not included for the radiographic
evaluation: the first because it was a non-weight-bearing
radiograph; the second because although it was prescribed as
weight-bearing, in some cases it was not performed because
the patients had pain or were afraid to place the operated
foot on the ground without an orthopedic shoe. Finally,
the clinical-functional and radiographic data were compared
based on patients’ demographic parameters (age, gender,
BMI, and smoking) and the number of osteotomies.
2.9. Clinical Functional Outcome Measures. The clinical pre-
operative evaluation included a complete clinical history of
the patients, their main characteristics (age, gender, BMI,
dominant side, smoking, occupation, and anesthesia ASA
class), and physical examination of the foot for preoperative
planning, as well as the percutaneous procedures to perform
(number of metatarsals to treat). To evaluate clinical out-
comes at the preoperative period and last follow-up (FU),
the following and most used questionnaires for forefoot
assessment were used according to our study protocol:
(i) The 100-point AOFAS hallux metatarsophalangeal-
interphalangeal scale [35, 36] was the only question-
naire used to assess clinical outcomes at the different
FU points (preoperatively, 3-, 6-, and 12-month FU),
and the difference of median values (Δ) between
preoperative and the last evaluation was calculated;
(ii) The Foot Functional Index (17-FFI) [35, 37] to mea-
sure the persistence of pain, disability, and restriction
of activity with 17 number rating scales from 0 to 10;
(iii) The Manchester-Oxford Foot Questionnaire
(MOXFQ) [35] to establish how frequent the restric-
tions in specific situations were, including 16 ques-
tions divided into three basic domains: pain (five),
walking/standing (seven), and social interaction
(four);
(iv) The Short Form 36 (SF-36) to identify the overall
health reported by the subjects;
(v) The Visual Analog Scale (VAS) to quantify patient
satisfaction with a score from 0 to 10.
Finally, during the last clinical check-up, patients were asked
about their ability to work and possible modification of
their daily activities. Additionally, any complications were
recorded.
2.10. Radiographic Outcome Measures. Routine standing
anteroposterior and lateral X-ray views were obtained before
surgery, at discharge, at one-month after surgery, and at
different FUs (3-, 6-, 12-month, and last FU), according to
our study protocol (Figures 5 and 6), respecting the Maestro
method (weight-bearing, 15∘-30∘ inclination of the X-ray
beam, 1m distance from the foot to the X-ray source).
They were analyzed at our institution in a standardized
manner using electronically computer-assistedMaestromea-
surements for weight-bearing radiographs provided by our
MedStation program (the X-ray database of our hospital).
This software allows the retrieval of electronically computer-
assisted measurements from weight-bearing radiographs to
minimize investigator bias.
Our sample was classified radiographically according to
Maestro and Besse criteria [9], adding to this classification
one more group to include those feet that did not reflect
any morphotype as defined by Maestro parameters (Table 1).
Hence, our cohort was divided into the following:
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Figure 5: (Case 1): a 47-year-old female patient having undergone DMMO of the M2, M3, and M4 in addition to Reverdin-Isham and Akin
percutaneous osteotomies for HV correction of her left foot. Radiographic images of anteroposterior (A) and lateral views (B): at preoperative
period (1), immediate postoperative period (2), 1-month follow-up (3), 3-month follow-up (4), 6-month follow-up (5), 12-month follow-up
(6), and 52 months after surgery (7), showing bone callus consolidation and its remodeling, maintaining the shortening and elevation of the
head of the MBs treated.
Figure 6: (Case 2): a 58-year-old female patient having undergone DMMO of the M2, M3, and M4 in association with Endolog technique
for HV correction of her left foot, radiographic images of anteroposterior (A) and lateral views (B): at preoperative period (1), immediate
postoperative period (2), 1-month follow-up (3), 3-month follow-up (4), 6-month follow-up (5), 12-month follow-up (6), and 48months after
surgery (7), showing bone callus consolidation and its remodeling, maintaining the shortening and elevation of the head of the MBs treated.
(1) Harmonious Morphotype, “normal forefoot,” charac-
terized by the SM4 line starting from the center of the
lateral sesamoid bone and passing through themiddle
third of the 4th metatarsal (M4) head, perpendicular
to the sagittal foot axis, and a geometrical progression
of 2 of the lesser metatarsals;
(2) Nonharmonious Morphotype-1, characterized by the
SM4 line passing through the middle third of the
M4 head, but the geometric progression of the lesser
metatarsals is altered; M2 and M3 are too long;
(3) Nonharmonious Morphotype-2 is the “M4M5
hypoplasia” morphotype, in which the SM4 line is
disjointed and the perpendicular line to the M2 axis
from the center of the sesamoid bone is distal to the
middle third of the M4 head; the perpendicular line
from the fifth metatarsal tip to the sagittal M2 axis
is proximal to the distal pole of the lateral sesamoid
bone (0.5–2 cm in severe hypoplasia);
(4) Nonharmonious Morphotype-3, “M1 long,” character-
ized by a geometrical progression of 2 of the lesser
metatarsal, which is generally correct; however, the
SM4 line is displaced distally because the lateral
sesamoid migrates distally with the M1 head.
(5) Unclassified Nonharmonious Morphotype: this last
group (our addition) includes all patients who do not
belong to any of the forefoot morphotypes described
by Maestro.
The radiographic evaluations included the Maestro criteria
index [9] using the preoperative and the last FU anteropos-
terior standing X-rays. The relative length of each metatarsal
was determined by drawing a line perpendicular to the axis
of the foot and then measuring the distances (in millimeters)
from each metatarsal head to this line (Figure 1), while also
taking into account the relationship between the length of M1
and the length of the remaining MBs.
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Table 1: Classification of forefoot morphotypes according to Maestro criteria, including the added unclassified ones.
Forefoot
Morphotypes Maestro Radiographic Parameters
Percentage usually in the
normal population
Study Cohort
Preoperative LastFollow-up
Harmonious
Harmonious Geometrical progression of
2 of the lesser M-bones with tolerance of
20% (±1 mm for M2M3 and M3M4, ±
2mm for M4M5)
31% 7.5%(7/93)
3.2%
(3/93)
Non-harmonious 1
M2M3 increased with M3M4 and M4M5
normal;
M2M3 decreased with M3M4 increased
and M4M5 correct;
M2M3 normal with M3M4 increased and
M4M5 correct;
M2M3 and M3M4 increased with M4M5
correct.
30% 32.3%(30/93)
20.4%
(19/93)
Non-harmonious 2 M4M5 hypoplasia: M3M4 and M4M5increased 37%
43%
(40/93)
18.3%
(17/93)
Non-harmonious 3 M1 >M2 2.4% 0%(0/93)
0%
(0/93)
Unclassified
Non-harmonious Feet that did not reflect any Morphotype -
17.2%
(16/93)
58.1%
(54/93)
In anteroposterior and lateral standing view radiographs,
callus formation and the absence of radiolucent lines were
checked to determine bone union at the different FUs. Com-
plete osteotomy healing time was then analyzed in relation
to the main patient parameters and procedure variables,
according to the study protocol (age, sex, BMI, smoking
status, and number ofMBs treated), in order to verify possible
statistically significant correlations.
2.11. Statistical Analysis. Statistical analyses were performed
by an independent statistician from the Department of
Statistics at our University. The data is presented as the mean
(plus standard deviation) or median (range) for continuous
variables and as numbers for categorical measures. For the
statistical evaluation of the clinical and radiological scores
obtained with the various scales and the parameters of the
Maestro formula before surgery and at last FU, we used
Student’s t-test. The Wilcoxon test was used to analyze the
relationship between the variations of the healing time and
the following variables: age, BMI, smoking status, and the
number of metatarsals on which we performed osteotomies.
Statistical significance was considered for p < 0.05.
3. Results
3.1. Patient Data. During a five-year period, 131 Cau-
casian patients (131 feet) with diagnosis of persistent central
metatarsalgia were treated by DMMO in a single foot at
our institution. We could not evaluate 38 patients (38 feet)
as 12 refused to participate in FU assessment (one was
unsatisfied with the clinical results and refused to come
back for evaluation, and the remaining 11 were pleased with
their results but were unable to come for evaluation); 6 did
not complete clinical and/or radiographic assessment of the
different FU points according to our postoperative control,
while at the time of the last FU evaluation, 7 were located
in a home for the elderly, 2 were dead, and a FU address
could not be retrieved for 11 people. Hence, 93 patients (93
feet) completed different FUs until the last one according
to the study protocol (Table 2). There were 14 men (15.1%)
and 79 women (84.9%). At the time of surgery, the mean
age was 62.4 ± 13.4 (range 31 to 87) years. The average FU
period was 58.7 ± 12.7 (range 36 to 96) months, and most
of the patients (53; 56.9%) were operated on between 60
and 79 years of age. In 43 cases (46.2%), the dominant limb
was affected, while the nondominant limb was affected in 50
cases (53.8%). Regarding risk factors, 16 patients were obese
(17.2%), 21 (22.6%) were active smokers, and 22 (23.7%) had
comorbidities (hypertension, BPCO, and vascular disease).
Hence, according to the ASA (American Society of Anesthe-
siologists) classification for globally estimated surgical risk,
there were 56 ASA 1 patients (60.2%), 26 ASA 2 patients
(28%), and 11 ASA 3 patients (11.8%).
During the 93 single foot operations, 198 DMMOs were
performed as follows: osteotomies were localized only on
the M2 in 23 feet (24.7%), on M2 and M3 in 35 (37.6%),
and finally on three metatarsals (M2-M3-M4) in 35 (37.6%)
(Table 3). In 86 (92.5%) of the 93 feet, associated procedures
were performed tailored to patient’s clinical presentation.
Reverdin-Isham percutaneous osteotomy was performed in
29 feet for the correction of mild-moderate HV deformities
and Endolog technique in 52 feet for moderate-severe ones,
followed by percutaneous Akin osteotomy and percutaneous
lateral soft-tissue release in some cases, according to our pro-
tocol. Further, we carried out flexor and extensor tenotomies
in 31 feet for the correction of claw toe flexible deformities and
associated osteotomies of the proximal phalange in 16 feet for
the correction of fixed ones.
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Table 2: Patients’ characteristics and their potential risk factors:
mean (± standard deviation) and absolute (and relative) frequency
(%).
Demographic Parameters Value
Gender
Males 14/93 (15.1)
Females 79/93 (84.9)
Age (years) 62.4 ± 13.4
30 - 39 7/93 (7.5)
40 - 49 11/93 (11.8)
50 - 59 17/93 (18.3)
60 - 69 27/93 (29)
70 - 79 26/93 (27.9)
≥ 80 5/93 (5.4)
BMI (kg/m2) 25.7 ± 4.3
>30 16/93 (17.2)
Smoking
Yes 21/93 (22.6)
No 72/93 (77.4)
Right feet
Dominant 78/93 (83.9)
Left feet
Dominant 15/93 (16.1)
Comorbidities
Hypertension 2/93 (2.2)
COPD 19/93 (20.4)
Vascular disease 1/93 (1.1)
ASA
1 56/93 (60.2)
2 26/93 (28)
3 11/93 (11.8)
Abbreviations: ASA: American Society of Anesthesiologists; BMI: Body Mass
Index; COPD: Chronic Obstructive Pulmonary Disease.
3.2. Clinical Functional Outcomes. At the preoperative eval-
uation, the mean AOFAS score of the patients was 48.6 ± 7.3
(range 22 to 65) points. Limitation in daily and recreational
activities was present in 49 cases (52.7%). At different FU
points, the mean AOFAS score was 66.6 ± 8.4 (range 42
to 82) points, 72.3 ± 10.6 (range 42 to 87) points, and 75.6
± 12.1 (range 35 to 95) points at 3-, 6-, and 12-month FU,
respectively, while it was 84.1 ± 14.4 (range 35 to 100) points
at last FU. Hence, in our cohort, the AOFAS score improved
significantly after surgery with respect to the preoperative
value (p < 0.0001), reporting good and excellent results in 79
(84.9%) feet (Figure 7). The mean preoperative 17-FFI was
43.2 ± 9.7 (range 24.7 to 64.7) points, while the average at
last FU was 7.8 ± 12.2 (range 0 to 54.6) points. Hence, also
the 17-FFI improved significantly after surgery with respect
to the preoperative value (p < 0.0001). The mean MOXFQ-
Pain, -Walking, and -Social preoperative scores were 11.4 ±
2.4 (range 7 to 16) points, 15.8 ± 3.7 (range 10 to 23) points,
and 4.8 ± 1.4 (range 0 to 8) points, respectively, while their
mean values at last FU were 2.1 ± 3.1 (range 0 to 16) points,
3.9 ± 4.5 (range 0 to 24) points, and 0.8 ± 1.6 (range 0 to 8)
100
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Figure 7: Graph of the statistical analysis of AOFAS scores at
preoperative period, 3-6-12 months after surgery, and mean last
follow-up of 58.7 months.
points, respectively (Figure 8). The two components of the
SF-36 (ISF and ISM) had, respectively, an average of 49.5 ±
8.6 (range 23.2 to 63.9) points and 49.5 ± 8.6 (range 23.2
to 63.9) points preoperatively, while being 49.5 ± 8.6 (range
23.2 to 63.9) points and 50.7 ± 7.5 (range 11.4 to 63.6) points
at last FU, respectively. The mean VAS score was 2.4 ± 1.7
(range, 0 to 6) points at last FU, with respect to 5.1 points at
the preoperative period. Among the patients operated on, at
last FU, 49 (52.7%) kept their job after surgery and 2 (2.1%)
had to change. The other patients were retired (23.7%) or
homemakers (22.6%). In addition, 73 (78.5%) patients did
not change their shoes. There was a reduction of patients
with hyperkeratosis (from 77.4% to 9.7%) andMTP instability
(Lachman test positive from 41.9% to 19.4%), as well as
clinical signs of dorsal subluxation (from 15.1% to 6.5%) of
these patients.
3.3. Radiographic Outcomes. In our sample, all radiographic
parameters of theMaestro criteria were significantly different
at the last FU compared to the preoperative period (p< 0.001).
The forefoot Harmonious Morphotype, presented in 7 cases
(7.5%) in the preoperative period, was identified only in 3
cases (3.2%) at last FU. A Nonharmonious Morphotype-1 was
present in 30 cases (32.3%) preoperatively with respect to 19
cases (20.4%) at last FU. ANonharmoniousMorphotype-2was
present in 40 cases (43%) preoperatively with respect to 17
cases (18.3%) at last FU, and an Unclassified Morphotype was
present in 16 cases (17.2%) with respect to 54 cases at last FU
(58.1%). No cases of forefoot Nonharmonious Morphotype-3
were found (Table 1).
Signs of bone callus formation were observed in 71 out
of 93 feet (76.3%) at 3 months FU, while the other patients
(23.7%) presented signs of osteotomy consolidation at 6
months postoperatively.Hence, all osteotomieswere healed at
6 months after surgery (Figures 5(A5)-(B5) and 6(A5)-(B5)).
The analysis of the possible variation of healing time based on
patient parameters considered (age, sex, BMI, smoking, and
number of metatarsals operated on) did not show statistically
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Table 3: Number of the metatarsal bones operated on according to the foot side and number of osteotomies performed by DMMO in our
series.
Site of osteotomy Feet treated by DMMO Number of DMMO Performed
Right feet Left feet Total
M2 11 (24.4%) 12 (25%) 23 (24.7%) 23 (11.6%)
M2-M3 17 (37.8%) 18 (37.5%) 35 (37.6%) 70 (35.4%)
M2-M3-M4 17 (37.8%) 38 (37.5%) 35 (37.6%) 105 (53%)
Total 45 (48.9%) 48 (51.6%) 93 (100%) 198 (100%)
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Figure 8: Graphs of the statistical analysis of 17-FFI (a), MOXFQ-PAIN (b), MOXFQ-WALKING (c), and MOXFQ-SOCIAL (d) scores (p <
0.0001), shown for each of the results at preoperative period and at mean last follow-up of 58.7 months.
significant correlation: age (p > 0.1621), gender (p > 0.5923),
BMI (p > 0.3234), smoking habits (p > 0.9638), and number
of metatarsals operated on (p > 0.3571).
3.4. Complications. Short-term complications were present
in 31 cases (33.3%): swelling (27 patients, 29%) and pares-
thesia (6, 6.4%), all resolved within 3 months from surgery.
In addition, there were 23 cases (24.7%) of delayed union,
completely healed at 6-month FU. Because of portal burns
during operation, 3 patients (3.2%) presented delayed wound
healing, which healed completely in four weeks and did
not require subsequent surgery. Long-term complications
were recorded in 12 cases (12.9%): 9 cases (9.7%) of persis-
tent stiffness (ROM: < 30∘) and 3 cases (3.2%) of transfer
metatarsalgia on the M4. The latter patients were subjected
to additional DMMO of the symptomatic MB.There were no
infections, nonunion or malunion of the osteotomy, floating-
toe deformity, soft tissue complications, residual instability
or subluxation, or evidence of avascular necrosis of the
metatarsal head.
4. Discussion
In the last fifteen years, DMMO became popular in Europe
by the Spanish surgeon De Prado first and then by the
GRECMIP (Groupe de Recherche et d’Enseignement en
Chirurgie Mini-Invasive du Pied) as an alternative surgical
technique to the traditional Weil osteotomy. Because of
the perceived potential advantages of a dynamic correc-
tion offered by DMMO, and the stiffness and floating toe
caused by Weil osteotomy [19], the percutaneous procedure
now tends to be preferred over open osteotomies [10, 23].
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However, the optimal treatment of metatarsalgia and the
restoration of an ideal forefoot morphotype remain contro-
versial [2, 3].
The purposes of this prospective study were first to
specifically evaluate the safety and effectiveness of DMMO in
treating persistent central primary metatarsalgia, identifying
possible contraindications. The second was to verify the
potential of DMMO in restoring a harmonious foot morpho-
type according to Maestro criteria and if these radiographic
criteria are correlated with clinical outcomes, maintaining a
predictive value for these criteria in the preoperative planning
for this technique.
In our cohort, clinical outcomes improved significantly in
each clinical score after surgery with respect to preoperative
values, and the clinical results at the last FU were satisfactory
(Figures 7 and 8). The AOFAS and MOXFQ scores over time
showed a statistically significant improvement (p < 0.0001).
The 17-FFI scores, which evaluate the clinical-functional
appearance of the foot, showed excellent results with a statis-
tically significant difference between pre- and postoperative
periods (p < 0.0001). A significant reduction of pain (VAS
scale: 2.4 vs 5.1 points) and formation of plantar callosities
was obtained, associated with a considerable improvement in
the quality of daily life in our patients as shown by SF36 (p
< 0.0001). Further, osteotomy consolidation was present in
76.3% of feet after 3 months from surgical operation and in
100% at 6-month FU.The incidence of recurrence or transfer
lesions was negligible. Henry [17] found similar healing times
for DMMO, confirming that this technique requires longer
healing time than the Weil osteotomy but with better results.
Further, our results showed no variation of healing time
based on age, sex, BMI, smoking, and number of metatarsals
treated.
Jarde´ [18] affirmed that the patients in whom postopera-
tive alignment of the metatarsal heads after Weil osteotomies
had most closely met the Maestro criteria had better results
than those in whom thematch was less exact [9, 14].However,
in our patient group, reconstruction of an ideal curve of
Maestro was obtained only in three of 93 of feet (3.2%),
despite precise preoperative planning (Table 1). Hence, we
found no correlation between having a harmonious and
mathematically correct distalmetatarsal parabola and clinical
outcomes. In fact, our study showed that although the
restoration of the ideal harmonious architectural Maestro
curve of the forefoot was not achieved by DMMO, the
procedure guaranteed balanced redistribution of the plantar
pressure forces and relief of metatarsalgia not only in the
immediate postoperative period, but also at medium-long
term FU.
In our series, 81 feet (87%)were operated on concurrently
for associated HV, in which instability of the first ray is impli-
cated and can be a predisposing or exacerbating cofactor for
metatarsalgia. This hypermobility is usually radiographically
and clinically assessed in both sagittal and coronal planes,
in the latter, in dorsal and also in dorsomedial directions, as
recently proposed [38]. Similarly, a more complete approach
to preoperative planning for metatarsalgia treatment, such as
the research for new criteria and morphotypes in the coronal
plane, should be promoted, as in a previous study of the pre-
operative planning of the Weil osteotomy [27]. In fact, Bev-
ernage concluded that radiographic preoperative planning
for metatarsalgia treatment only in the anteroposterior plane
is clearly a simplification of a complex pathology because
this pathology requires a three-dimensional correction [27].
The ideal preoperative planning for the more recent DMMO
should take into account the potential proximal shift of the
osteotomized metatarsal heads in both sagittal and coronal
planes. However, this assessment is difficult to carry out
as it should foresee the metatarsal head displacement not
only at the operating table but also after load resumption
by walking in the postoperative period, identifying new
radiological and biomechanical criteria for the ideal foot
morphotype. From our results, it is questionable if Maestro
parameters can adequately represent this, maintaining their
predictive value. After DMMO, the metatarsal heads consoli-
date into amore proximal position due tomechanical loading
allowed after surgery by weight-bearing. This is in contrast
to the Weil procedure, where the osteotomies, synthesized
by screws, remain fixed after surgery, reflecting the ideal
position calculated by the preoperative planning. For these
reasons, it is the opinion of the authors that there is a need
for revised radiological criteria that correlate radiological
metatarsal alignment with clinical outcomes before and after
this percutaneous technique.
Numerous complications related to DMMO have been
reported [14, 19, 32, 39], but in our study, we had a low
rate of short-term complications, such as transitory swelling,
paresthesia, and skin burns, while delayed unions were
resolved by 6-month FU. The main long-term complication
was persistent stiffness (9.7%), and 3 cases (3.2%) of transfer
metatarsalgia were resolved with a second percutaneous
operation by M4 osteotomy. We had no cases of floating-
toe deformity, residual instability or subluxation, infection,
pseudarthrosis, avascular necrosis, or displacement of the
metatarsal head, which are the most undesirable complica-
tions [14, 15, 22, 32]. We did not identify any risk factors
that increased complications in our group. Redfern does not
recommend DMMO in the presence of significant arthritis
and stiffness of MTPJ because it is associated with increased
risk of pseudarthrosis. However, this aspect was one of our
exclusion criteria.
To the best of our knowledge, this is the first prospec-
tive, single-center study reporting clinical and radiographic
outcomes of DMMO for the treatment of primary central
metatarsalgia in a consecutive, single-surgeon patient series.
The number of patients and the mean FU of almost 60
months were superior to previous published studies [25, 26,
30, 32]. For clinical evaluation of our sample, internationally
validated scores were used, except for the AOFAS score,
which, although it remains the most widespread health
measurement in foot and ankle clinical practice, has been
only partially validated [36]. For radiographic evaluation,
the traditional method of Maestro [9] was used to perform
X-ray foot images and to classify them both pre- and
postoperatively, even to determine which MBs to shorten
by DMMO during preoperative planning. The findings of
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this study should be interpreted within the context of its
limitations. They are partially linked to the limited scientific
literature on this subject and the poverty of cases of pure
metatarsalgia. Most of the feet in our cohort included HV
deformity, causing a potential bias of this study, and plantar
pressure measurements were not performed.
5. Conclusion
First, Distal Metatarsal Metaphyseal Osteotomy (DMMO),
often associated with percutaneous or open techniques for
HV correction and percutaneous soft tissue and/or bone
procedures in cases of lesser toe deformities, is a safe and
effective minimally invasive method for the treatment of
biomechanical central metatarsalgia. Further, age, gender,
BMI, and smoking are not potential contraindications. Thus,
DMMO can be considered a suitable alternative technique
to traditional ones. Second, during preoperative planning,
Maestro criteria were proved to be useful to calculate which
MBs needed to be shortened to prevent transfer metatarsalgia
and a significant clinical improvement of all scores assessed
was noted at last follow-up. However, the ideal harmonious
curve of the forefootwas restored byDMMOonly in a few feet
and a limited number of harmonious forefoot morphotypes
were consequently found in the postoperative period. Hence,
our data show that Maestro criteria do not have a predictive
value in clinical outcomes of DMMO. Additional studies are
required to find radiographicmeasurementsmore specific for
the preoperative planning of this percutaneous technique.
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